New software tool for analyzing kinases; Dotmatics software to support Cancer Therapeutics CRC;

> R&D software provider Dotmatics says that Cancer Therapeutics CRC has deployed the company's enterprise platform for research at multiple locations. Item

> Formedix has spotlighted the company's latest Transform for Publication products for clinical trials data. Release

> A group from the University of Saskatchewan has developed software to analyze kinases, which, when mutated, are culprits in a number of cancers. Announcement

> An informatics expert from the Ohio State University plans to upgrade a web-based tool for analyzing large datasets to help researchers explore the spread of infectious diseases. Report

> Biovest International ($BVTI) has tapped Dr. Eduardo Sotomayor of the H. Lee Moffitt Cancer Center & Research Institute in Tampa for its scientific advisory board. Release



BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.